BDBM329712 1-(1-(2-chloro-6- (trifluoromethyl)benzoyl)-6- (hydroxymethyl)- 1H-indazol-3- yl)piperidine-4- carboxylic acid::US9663522, 1S

SMILES OCc1ccc2c(nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2c1)N1CCC(CC1)C(O)=O

InChI Key InChIKey=OKOJQLRHIVELON-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329712   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM329712(US9663522, 1S | 1-(1-(2-chloro-6- (trifluoromethyl...)
Affinity DataIC50: 317nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent